Glutathione: Dosage, Benefits & Side Effects
By Peptide Assistant Editorial Team · · · 12 sources cited
Overview
Glutathione (GSH) is a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's most abundant intracellular antioxidant. It plays critical roles in detoxification, immune function, and cellular redox balance. Injectable glutathione has become widely used for skin lightening, liver detoxification support, and systemic antioxidant therapy. Levels decline with age, illness, and environmental toxin exposure.
Mechanism of Action
Glutathione functions as the cell's primary redox buffer and detoxification agent. In its reduced form (GSH), it donates electrons to neutralize reactive oxygen species (ROS), reactive nitrogen species, and lipid peroxides — converting to oxidized glutathione (GSSG) in the process. The enzyme glutathione reductase then regenerates GSH from GSSG using NADPH, maintaining the critical GSH:GSSG ratio above 100:1 in healthy cells. Glutathione is essential for Phase II liver detoxification, where glutathione S-transferase (GST) enzymes conjugate GSH to xenobiotics, drugs, and carcinogens, making them water-soluble for excretion. For skin lightening, glutathione inhibits tyrosinase and shifts melanin synthesis from eumelanin (dark) to pheomelanin (light). It also recycles vitamins C and E, maintaining the antioxidant network. In immune cells, glutathione is required for T-lymphocyte proliferation and natural killer cell activity.
Glutathione Benefits: What the Research Shows
- A randomized controlled trial in the Journal of Dermatological Treatment (2012) showed oral glutathione (500 mg/day for 4 weeks) reduced melanin index at two of six skin sites, and UV spots, in 60 Thai medical students
- A 2025 systematic review found only one placebo-controlled study of IV glutathione for skin lightening, which showed no significant benefit (37.5% vs 18.7% of patients improved), and advised against IV use because of side effects
- Studies show blood glutathione levels tend to decline with advancing age, contributing to age-related oxidative stress accumulation
- A 6-month randomized trial in the European Journal of Nutrition (2015) found oral glutathione (250 or 1,000 mg/day) raised body glutathione stores and lowered the ratio of oxidized to reduced glutathione in blood
- Research in HIV-positive patients showed 13 weeks of liposomal glutathione supplementation raised TH1 cytokine levels and lowered free radical levels (Journal of Interferon & Cytokine Research, 2015)
- A randomized pilot trial of IV glutathione in 21 Parkinson's disease patients found no significant improvement in symptom scores, and intranasal glutathione was no better than placebo in a 45-patient trial
Glutathione Dosage
- IV push: 600–2,000 mg, 1–3 times weekly (clinical/aesthetic settings)
- Subcutaneous injection: 200–600 mg daily or every other day
- Oral (liposomal): 250–500 mg daily — standard oral bioavailability is poor (<5%), liposomal improves this to ~30%
- Nebulized: 300–600 mg in saline for respiratory conditions (under medical guidance)
- Skin lightening protocol: 600–1,200 mg IV twice weekly for 8–12 weeks, then maintenance monthly
- Detoxification support: 600 mg IV 2–3 times weekly during detox protocols
- Often combined with IV vitamin C (1–2 g) for enhanced antioxidant synergy
Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.
Glutathione Side Effects & Safety
Known Side Effects
- IV administration: mild flushing, warmth, or headache during infusion
- Subcutaneous injection: stinging at injection site (glutathione solutions can be acidic)
- Bloating or cramping with oral supplementation
- Rare: allergic-type reactions (rash, difficulty breathing) — primarily with IV route
- Theoretical concern: long-term high-dose IV glutathione may deplete zinc and copper
- Skin lightening effects are temporary and reverse upon discontinuation
Safety Profile
Glutathione is an endogenous molecule, and short trials (a few IV doses, or 4–12 weeks of oral use) reported no or minimal adverse effects. No study has reported on long-term IV use. The IV route gives the highest blood levels but carries standard IV infusion risks (infection, phlebitis, air embolism). In the skin-lightening context, long-term safety of high-dose IV glutathione has not been extensively studied — the Philippines FDA has issued cautions about high-dose IV glutathione for cosmetic use. Individuals with sulfite sensitivity should use caution. Those on chemotherapy should consult their oncologist, as glutathione may theoretically protect cancer cells from oxidative damage. In 2019 the US FDA warned compounders after seven patients had reactions (including nausea, vomiting, chills, low blood pressure and difficulty breathing) to IV glutathione compounded from dietary-supplement-grade powder that contained excess endotoxin.
What to Expect
Week 1–2: Subtle improvements in energy and mental clarity as oxidative burden reduces. Some users note brighter-looking skin within days of IV treatment. Weeks 3–4: Skin lightening effects become noticeable (if using for this purpose). Improved complexion clarity and reduced dark spots. Enhanced exercise recovery. Weeks 5–8: Cumulative antioxidant benefits — improved liver function markers, better skin quality, reduced inflammation. Skin lightening progresses. Months 2–3+: Maximum skin lightening achieved. Systemic benefits include better detoxification capacity, improved immune markers, and sustained energy. Effects reverse gradually over weeks to months after discontinuation.
Common Stacks
GHK-Cu
GHK-Cu upregulates glutathione-related genes while exogenous glutathione provides immediate antioxidant substrate — synergistic cellular protection
Thymosin Alpha-1
Glutathione supports the immune cells that Thymosin Alpha-1 activates, creating a comprehensive immune support stack
NAD+
NAD+ and glutathione are both critical for cellular redox balance — together they support mitochondrial function and detoxification pathways
Storage & Handling
Lyophilized glutathione: store at 2–8°C for up to 12 months or -20°C for longer storage. Reconstituted solution: refrigerate and use within 1–2 weeks (glutathione oxidizes readily once in solution). Protect from light. Liposomal oral formulations: store per manufacturer instructions, typically refrigerated after opening. Discard if solution turns yellow (indicates oxidation to GSSG).
Pricing & Available Variants
Prices sourced from peptides.gg marketplace. Prices may vary.
References
- FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables (Compounding Alert, June 7, 2019). U.S. Food and Drug Administration. 2019.
- Sarkar R, Yadav V, Yadav T, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025.
- Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012.
- Davids LM, Van Wyk JC, Khumalo NP. Intravenous glutathione for skin lightening: Inadequate safety data. S Afr Med J. 2016.
- Alzahrani TF, Alotaibi SM, Alzahrani AA, et al. Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review. Cureus. 2025.
- Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015.
- Witschi A, Reddy S, Stofer B, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992.
- Sinha R, Sinha I, Calcagnotto A, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr. 2018.
- Detcheverry F, Senthil S, Narayanan S, et al. Changes in levels of the antioxidant glutathione in brain and blood across the age span of healthy adults: A systematic review. Neuroimage Clin. 2023.
- Villarama CD, Maibach HI. Glutathione as a depigmenting agent: an overview. Int J Cosmet Sci. 2005.
- Hauser RA, Lyons KE, McClain T, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease. Mov Disord. 2009.
- Ly J, Lagman M, Saing T, et al. Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals. J Interferon Cytokine Res. 2015.
Related Peptides
Track Glutathione in Your Protocol
Log your Glutathione doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.
Start Tracking Free